This video clip sums up the rationale for and also disputes bordering recommendations made by the Medical Guidelines Committee of the American College of Physicians (ACP) in its 2018 Advice Statement on hemoglobin A1c (HbA1c) targets for glycemic control with pharmacology treatment for nonpregnant grownups with kind 2 diabetes mellitus. Elizabeth L. Tung, MD, MS, and also Neda Laiteerapong, MD, MS, both of the Chicago Facility for Diabetes Mellitus Translation Research Study in the Area of General Internal Medication at the University of Chicago, explain.
Pay attention to the podcast: https://ja.ma/2JQFRwg
Check Out the JAMA Medical News & Perspectives post: https://ja.ma/2lhtEli
Check Out the JAMA Clinical Guidelines Synopsis: https://ja.ma/2M1xbzA